Global Prostate Cancer Therapeutics Market to 2020
The global market for prostate cancer therapeutics is increasing, driven primarily by the growth in the hormonal therapy markets. The main drivers for the prostate cancer market are the increase in the global aging population, innovation in drugs and developments in genomics and proteomics.
Asia & Middle East Kidney Transplant Number and Market Analysis
With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen.
Global Proton Therapy Market and Centers Analysis
By 2018, the number of sites providing proton therapy in the US is expected to cross 25. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi Billion dollar potential market. In Unites States the numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are in Millions.
Worldwide - Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019
The hepatitis C market is rapidly evolving as new launches prompt a significant paradigm shift in the treatment of the disease. In 2011, a breakthrough in HCV therapy was witnessed with the first two direct acting anti-HCV drugs (Incivek and Victrelis) came to market and were followed by the market approval of two additional anti-HCV drugs (Sovaldi and Olysio) in 2013.